Actively Recruiting
Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics
Led by Cardenal Herrera University · Updated on 2026-03-27
200
Participants Needed
2
Research Sites
95 weeks
Total Duration
On this page
Sponsors
C
Cardenal Herrera University
Lead Sponsor
B
Beaty Dent
Collaborating Sponsor
AI-Summary
What this Trial Is About
Background This study is part of a doctoral research project at Universidad Cardenal Herrera CEU (Spain), directed by Prof. Santiago Arias de Luxán and conducted by doctoral candidate Shirli Kelmendi within the PhD program in Translational Medicine. Fixed orthodontic appliances complicate oral hygiene by creating retention areas that favor bacterial colonization and alter microbial balance. These conditions increase plaque accumulation and Streptococcus mutans (S. mutans) proliferation in saliva and plaque. The frequent low-pH environment favors aciduric bacteria such as S. mutans and lactobacilli, promoting enamel demineralization and formation of white spot lesions (WSLs) or cavitations. WSLs appear as opaque white areas due to subsurface mineral loss, mainly in the gingival third of the crown. They may develop as early as one month after bracket placement, while in patients without appliances, progression occurs after at least six months. Increased S. mutans levels have been reported as early as six weeks after treatment start. Risk factors include poor brushing, lack of floss or rinse use, time since last cleaning, and presence of caries or lesions. Intervention MI Paste Plus (GC, Japan) is a remineralizing cream with 0.20% sodium fluoride (900 ppm) and 10% CPP-ACP (RECALDENT™), providing calcium and phosphate stabilized by casein phosphopeptides. It has antibacterial and remineralizing effects, suitable during or after orthodontic treatment to prevent or reduce WSLs. Objective To evaluate whether MI Paste Plus during fixed orthodontic treatment reduces S. mutans counts in saliva and/or WSL incidence. Study Design A prospective, triple-blind, randomized clinical trial, approved by the Ethics Committee of the Ministry of Health of Albania and the Ethics Committee for Human Research of Universidad Cardenal Herrera CEU, Spain. The study will include 200 patients (100 per group) from two orthodontic clinics in Tirana, Albania. Participants will be stratified by age, risk level, and appliance type, then randomized by third parties. Outcome Measures Primary variables: S. mutans counts in saliva and number of WSLs after 3 months. Standardized saliva collection, culturing, and bacterial quantification ensure consistency. Clinical assessments will be performed at 1 and 3 months using QRay Cam Pro (Inspektor Systems, Netherlands) for quantitative fluorescence and ICDAS for visual inspection. Data will be analyzed using SPSS/R Commander software.
CONDITIONS
Official Title
Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 5 and 45 years
- Starting fixed orthodontic treatment with fixed auxiliary appliances or brackets
- General good health with no systemic diseases affecting oral health
You will not qualify if you...
- Advanced white-spot lesions with untreated dentin involvement
- Active untreated dental caries at baseline
- Antibiotic therapy within the previous two months
- Previous diagnosis of molar-incisor hypomineralization (MIH)
- History of immunosuppression
- Iron-deficiency anemia or other clinically relevant hematological disorders
- Parafunctional habits such as lip sucking or finger sucking
- Use of any type of dental prosthesis
- Smoking or tobacco use
- Documented allergy to nickel
- Requirement for orthodontic treatment using removable appliances or clear aligners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Beaty Dent
Tirana, Albania, Albania, 1001
Actively Recruiting
2
Happy Dent
Tirana, Albania, Albania, 1001
Not Yet Recruiting
Research Team
S
Santiago Arias de Luxán, DMD, PhD
CONTACT
S
Shirli Kelmendi, DMD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here